نتائج البحث

A Study of BAX 930 in Children, Teenagers, and Adults Born With Thrombotic Thrombocytopenic Purpura (TTP)

• Authors : Takeda Development Center Americas, Inc.

• Source: A Phase 3, Prospective, Randomized, Controlled, Open-label, Multicenter, 2 Period Crossover Study With a Single Arm Continuation Evaluating the Safety And Efficacy of

تفاصيل العنوان

Correlated flat bands in the paramagnetic phase of triangular antiferromagnets Na$_2$BaX(PO$_4$)$_2$ (X = Mn, Co, Ni)

• Authors : Hu, Cong; Zhang, Xuefeng; Su, Yunlong

Subjects: Condensed Matter - Strongly Correlated Electrons; Condensed Matter - Materials Science; Physics - Computational Physics

تفاصيل العنوان

Multipoint-BAX: A New Approach for Efficiently Tuning Particle Accelerator Emittance via Virtual Objectives

• Authors : Miskovich, Sara A.; Neiswanger, Willie; Colocho, William

Subjects: Physics - Accelerator Physics; Computer Science - Artificial Intelligence; Computer Science - Machine Learning

• Source: Machine Learning: Science and Technology, Dec. 2023

تفاصيل العنوان

A Study of BAX 888 in Male Adults With Severe Hemophilia A

• Authors : Baxalta Innovations GmbH, now part of Shire; Takeda Development Center Americas, Inc.

• Source: A Global, Open-Label, Multicenter, Phase 1/2 Study of the Safety and Dose Escalation of BAX 888, an Adeno-Associated Virus Serotype 8 (AAV8) Vector Expressing B-Domain

تفاصيل العنوان

BAX 855 PK-guided Dosing (PROPEL)

• Authors : Baxalta Innovations GmbH, now part of Shire

• Source: Phase 3, Prospective, Randomized, Multi-center Clinical Study Comparing the Safety and Efficacy of BAX 855 Following PK-guided Prophylaxis Targeting Two Different FVIII

تفاصيل العنوان

Study Investigating a PEGylated Recombinant Factor VIII (BAX 855) for Hemophilia A (PROLONG-ATE Study)

• Source: A Phase 2/3, Multi-Center, Open Label Study of Efficacy, Safety, and Pharmacokinetics of PEGylated Recombinant Factor VIII (BAX 855) Administered for Prophylaxis and

تفاصيل العنوان

BAX 855 Dose-Escalation Safety Study

• Authors : Baxter Innovations GmbH

• Source: BAX 855 (PEGylated Recombinant Factor VIII): A Phase 1, Prospective, Open Label, Cross-Over, Dose-Escalation Study in Previously Treated Patients (PTPs) With Severe

تفاصيل العنوان

BAX 855 Pediatric Study

• Source: Mullins ES, Stasyshyn O, Alvarez-Roman MT, Osman D, Liesner R, Engl W, Sharkhawy M, Abbuehl BE. Extended half-life pegylated, full-length recombinant factor VIII for prophylaxis in children with

تفاصيل العنوان

BAX 855 Continuation

• Authors : Baxalta Innovations GmbH, now part of Shire

• Source: A Phase 3b Continuation Study of the Safety and Efficacy of PEGylated Recombinant Factor VIII (PEG-rFVIII; BAX 855) in Prophylaxis of Bleeding in Previously Treated

تفاصيل العنوان

Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical Procedures

• Source: Brand B, Gruppo R, Wynn TT, Griskevicius L, Lopez Fernandez MF, Chapman M, Dvorak T, Pavlova BG, Abbuehl BE. Efficacy and safety of pegylated full-length recombinant factor VIII with extended

تفاصيل العنوان